2 results Stibbe advised Rhône Capital on a public cash offer for equity stake in RHI Magnesita Stibbe advised Rhône Capital on a public cash offer for up to 29.9% of the share capital in RHI Magnesita N.V. The offer document was published on 19 June 2023 following an announcement of the intended transaction on 30 May 2023. Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.
Stibbe advised Rhône Capital on a public cash offer for equity stake in RHI Magnesita Stibbe advised Rhône Capital on a public cash offer for up to 29.9% of the share capital in RHI Magnesita N.V. The offer document was published on 19 June 2023 following an announcement of the intended transaction on 30 May 2023.
Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.